Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

SHSE:688076 Stok Raporu

Piyasa değeri: CN¥15.1b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Jiangsu Sinopep-Allsino Biopharmaceutical Gelecekteki Büyüme

Future kriter kontrolleri 6/6

Jiangsu Sinopep-Allsino Biopharmaceutical is forecast to grow earnings and revenue by 33.5% and 31.1% per annum respectively. EPS is expected to grow by 34% per annum. Return on equity is forecast to be 21.7% in 3 years.

Anahtar bilgiler

33.5%

Kazanç büyüme oranı

34.0%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi18.5%
Gelir büyüme oranı31.1%
Gelecekteki özkaynak getirisi21.7%
Analist kapsamı

Low

Son güncelleme02 Sep 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Should You Be Adding Jiangsu Sinopep-Allsino Biopharmaceutical (SHSE:688076) To Your Watchlist Today?

Sep 26
Should You Be Adding Jiangsu Sinopep-Allsino Biopharmaceutical (SHSE:688076) To Your Watchlist Today?

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHSE:688076) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable

Jun 23
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHSE:688076) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable

Jiangsu Sinopep-Allsino Biopharmaceutical's (SHSE:688076) Shareholders May Want To Dig Deeper Than Statutory Profit

Apr 04
Jiangsu Sinopep-Allsino Biopharmaceutical's (SHSE:688076) Shareholders May Want To Dig Deeper Than Statutory Profit

There's Reason For Concern Over Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s (SHSE:688076) Massive 27% Price Jump

Mar 04
There's Reason For Concern Over Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s (SHSE:688076) Massive 27% Price Jump

Kazanç ve Gelir Büyüme Tahminleri

SHSE:688076 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20263,1548006146475
12/31/20252,344587-1814475
12/31/20241,724420-3663315
6/30/20241,464348-365376N/A
3/31/20241,181208-445284N/A
12/31/20231,034163-310350N/A
9/30/2023979168-271280N/A
6/30/2023784136-244217N/A
3/31/2023725134-218173N/A
12/31/2022651129-40929N/A
9/30/202257695-34933N/A
6/30/202260399-30780N/A
3/31/202261292-169168N/A
12/31/2021644115-53181N/A
9/30/2021642113-34173N/A
6/30/2021660126116245N/A
3/31/202168715954165N/A
12/31/202056712330141N/A
9/30/202048194-24104N/A
6/30/202042574-13165N/A
3/31/202035346-17766N/A
12/31/201937249-23046N/A
9/30/201931340-22090N/A
6/30/201926631-20562N/A
3/31/201929859-19843N/A
12/31/201825644-10196N/A
9/30/201828466-13723N/A
6/30/201828671-169-43N/A
3/31/201824546N/A40N/A
12/31/201722942N/A11N/A
9/30/2017156-7N/A51N/A
6/30/2017104-46N/A78N/A
3/31/201726-66N/A-4N/A
12/31/20169-75N/A-22N/A
9/30/20166-53N/A-79N/A
6/30/20163-33N/A-137N/A
3/31/20166-32N/A-125N/A
12/31/20159-30N/A-113N/A
12/31/2014N/A-25N/A68N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 688076's forecast earnings growth (33.5% per year) is above the savings rate (2.9%).

Kazançlar ve Piyasa: 688076's earnings (33.5% per year) are forecast to grow faster than the CN market (23.2% per year).

Yüksek Büyüme Kazançları: 688076's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: 688076's revenue (31.1% per year) is forecast to grow faster than the CN market (13.2% per year).

Yüksek Büyüme Geliri: 688076's revenue (31.1% per year) is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 688076's Return on Equity is forecast to be high in 3 years time (21.7%)

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y